Langzyklus bei Ovulationshemmern
review
OA: closed
CC0
⤵ 3 in-corpus citations
AI-generated summary
Longer cycles with oral contraceptives offer increased safety and reduced hormonal fluctuations, benefiting women who prefer fewer menstrual periods and addressing conditions like endometriosis and dysmenorrhea.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Surveys show that most women desire a change in their menstrual pattern in the sense that they would prefer less menstruations or even amenorrhea. On this behalf, there is no difference between women having spontaneous natural cycles and women taking the pill. The main reasons are less menstrual bleedings, better hygienic conditions, a better quality of life and less blood loss. In women wanting regular monthly periods, the opinion is dominant that suppression of menstrual bleedings is "unnatural". It is therefore primordial to inform women that contraceptive safety is even increased in users following the long-cycle principal and that a fertility decrease has not to be feared. The benefit of the long-cycle OC is a reduction of the hormonal fluctuations induced by the pill-free interval with its consecutive somatic and mental symptoms, as well as an increased contraceptive safety. The following cycle- and menstruation-dependent symptoms as listed as an indication for the long-cycle use: Endometriosis, hypermenorrhea, dysmenorrhea, hemorrhagic diathesis, uterine fibroma, polyzystic ovary syndrome, migraine due to estrogen-deficiency in the pill-free interval as well as premenstrual syndrome.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (2)
- Cyproterone acetate versus a continuous monophasic oral contraceptive in the treatment of recurrent pelvic pain after conservative surgery for symptomatic endometriosis 2002
- Extended and Continuous Use of Hormonal Contraceptives to Reduce Menstruation 2006
Cited by (3)
- Potential Therapeutic Options and Perspectives for Alleviation of Endometrial Estrogen Dominance and Progesterone Resistance in Endometriosis 2021
- Endometriosis - Recent Advances, New Perspectives and Treatments 2021
- Неконтрацептивные положительные эффекты комбинированных оральных контрацептивов 2013
References (28)
- Cyproterone acetate versus a continuous monophasic oral contraceptive in the treatment of recurrent pelvic pain after conservative surgery for symptomatic endometriosis via openalex
- Extended and Continuous Use of Hormonal Contraceptives to Reduce Menstruation via openalex
- W1977359187 via openalex
- W1977435928 via openalex
- W1979726874 via openalex
- W1984096098 via openalex
- W1995690188 via openalex
- W2005566479 via openalex
- W2012586124 via openalex
- W2015806567 via openalex
- W2030313543 via openalex
- W2035296610 via openalex
- W2049679640 via openalex
- W2053103786 via openalex
- W2079008410 via openalex
- W2087827870 via openalex
- W2092214166 via openalex
- W2113520440 via openalex
- W2118899690 via openalex
- W2127964780 via openalex
- W2128914859 via openalex
- W2144461493 via openalex
- W2167428807 via openalex
- W2274859249 via openalex
- W2282872105 via openalex
- W1697811015 via openalex
- W3148533209 via openalex
- W1967752715 via openalex
Cited by (3)
- Potential Therapeutic Options and Perspectives for Alleviation of Endometrial Estrogen Dominance and Progesterone Resistance in Endometriosis 2021
- Endometriosis - Recent Advances, New Perspectives and Treatments 2021
- Неконтрацептивные положительные эффекты комбинированных оральных контрацептивов 2013
SciLite annotations
organisms 2
noordeloos 2009062
noordeloos 2009062
chemicals 1
estrogen
Source provenance
- europepmc
- last seen: 2026-09-27T09:11:36.575535+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:14:18.065553+00:00
- scilite
- last seen: 2026-05-18T04:25:29.313245+00:00
- unpaywall
- last seen: 2026-09-29T06:34:56.587159+00:00
License: CC0
· commercial use OK